Share Your Neuroendocrine Cancer Diagnosis Journey and Help Shape the Future of Care
For many people living with neuroendocrine cancer, the journey to diagnosis can be long, complex and filled with uncertainty. Symptoms are often difficult to recognise, may be attributed to other conditions, or can be overlooked before the correct diagnosis is finally...
National Cancer Plan (England) Cancer52 Update: Progress Six Months On
The National Cancer Plan was launched to improve cancer prevention, diagnosis, treatment, research and support across England. Six months on, NHS England and the Department of Health and Social Care have provided an update on progress, highlighting areas of...
New patient platform aims to transform rare disease diagnosis through lived experience
A new initiative from Opalmedica is placing patient voices at the centre of efforts to improve rare disease diagnosis, with the launch of its innovative KLEOS™ platform. The platform is designed to tackle one of the most persistent challenges in rare disease care: the...